Myelodysplastic Syndromes (MDS)

Updates from ASH22 on MDS and AML

Thumbnail for video Watch Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting. Research findings are…

Damian Laber, MD

Institution
Moffit Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Laber is a hematologist/oncologist and senior member with Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital. Dr. Laber earned his M.D. at the University of Buenos Aires, Argentina. He completed his residency in internal medicine at Cleveland Clinic Health System, and was designated Chief Resident during his term at Hillcrest and Southpointe Hospitals. Dr. Laber’s research

Namrata Chandhok, MD

Institution
University of Miami Health System - Sylvester Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Chandhok, M.D. is a Hematologist and Oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Chandhok works as part of a multidisciplinary team treating patients with leukemia and myelodysplastic syndrome (myeloid malignancies) . She earned her medical degree from The George Washington University School of Medicine and Health Sciences, Washington DC. • Currently seeing patients with myeloid malignancies. • Avid participant in clinical trials. • Board certified in Internal Medicine and board eligible in Hematology and Oncology. • Completed her residency in Internal Medicine
Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.